SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-15-007157
Filing Date
2015-02-09
Accepted
2015-02-09 17:06:53
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYDR. MICHAEL F. POWELLDR. SRINIVAS AKKARAJUSOFINNOVA MANAGEMENT VIII, L.L.C

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v400792_sc13d.htm SC 13D 113746
  Complete submission text file 0001144204-15-007157.txt   115464
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88577 | Film No.: 15589360
SIC: 2836 Biological Products, (No Diagnostic Substances)